Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

Entrectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Metastatic Pancreatic Cancer.

In a report released today, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment ...

Cobimetinib fumarate is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Peritoneal Cancer.

Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous (IV) Tecentriq1,2New subcutaneous (SC) op ...

India - Conduct Of Defendants In A Quia Timet Action. Legal News and Analysis - India - Intellectual Property - Conventus Law ...

In a report released today, Emily Field from Barclays maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a ...

Researchers at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have described C-C chemokine receptor type 6 (CCR6) antagonists reported to be useful for the treatment of asthma, psoriasis, ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...

Patients with HER2-positive advanced or metastatic breast cancer received trastuzumab deruxtecan every 3 weeks.

Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...